Author

M. C. Faux

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Assay:proteomics· 1 Research Focus:synaptic & neural circuits· 1

Frequent Co-Authors

A. K. Voss· 1 shared A. Kueh· 1 shared A. W. Burgess· 1 shared B. Tran· 1 shared C. Hall· 1 shared C. McLean· 1 shared D. Frank· 1 shared D. Komander· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. K. Voss

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologyeLifePeer-reviewedDec 15, 2023

Trabid patient mutations impede the axonal trafficking of adenomatous polyposis coli to disrupt neurite growth

D. Frank, M. Bergamasco, M. Mlodzianoski…·H. Tran

This study identifies Trabid mutations that disrupt APC trafficking and neurite growth by impairing DUB activity or STRIPAK binding, leading to neurodevelopmental defects.

DOI 10.7554/elife.90796

mouseproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintFeb 28, 2021

Dual Drug Targeting to Kill Colon Cancer Cells

A. W. Burgess, M. C. Faux, S. P. Corona…·F. Walker

The paper investigates the effectiveness of dual drug combinations in killing colon cancer cells and identifies a viable oral treatment for xenograft models.

DOI 10.1101/2021.02.28.433288

mouseexperimental assay

𝕏 PostBluesky